PKI News and Press, PerkinElmer Inc. From 12/28/21

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Changing the rules The Centers for Disease Control and Prevention is updating recommendations for COVID-19 control, shortening isolation restrictions from ...

In a meeting with some of the nation's governors, President Biden pledged to support states struggling with the Omicron variant, but acknowledged that they will need to take the lead in controlling the pandemic. Arkansas Governor Asa Hutchinson, who is chair of the National Governors Associat...

The extremely high demand for at-home COVID-19 tests in the face of the rising number of cases is causing a spike in the share price of some test makers. Cue Health (HLTH +12.3%), Lucira Health (LHDX +13.6%), and Fulgent Genetics (FLGT +4.8%) are the three with the biggest gains today. Quidel...

The extremely highly demand for at-home COVID-19 tests in the face of the rising number of cases is causing a spike in the share price of some test makers. Cue Health (HLTH +12.3%), Lucira Health (LHDX +13.6%), and Fulgent Genetics (FLGT +4.8%) are the three with the biggest gains today. Quid...

Fourth vaccine: Israel is set to become the first country in the world to administer a fourth COVID-19 vaccine, which would give "greater protection in the face of Omicron." The first eligible group to receive the vaccine will be people age 60 and older, as well as the immunocompromised and m...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present virtually at the annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 11:15 a.m. ET. Prahlad Singh, president and chief...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

PerkinElmer (NYSE:PKI) has launched its NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 for research use which makes it faster and easier to detect virus variants. With positive SARS-CoV-2 samples, the kit detects mutations associated with all SARS-CoV-2 variants, including Omicron. PerkinElmer says t...

New NGS workflow accelerates the detection of SARS-CoV-2 variants including Omicron PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX ® Variant-Seq&#...

PerkinElmer (NYSE:PKI) says that the new Omicron variant will not impact the accuracy of its PCR tests to detect COVID-19. In silico assessment against variant databases have confirm that none of the mutations associated with Omicron impact the company's PerkinElmer's PCR based diagnostic kit...